Case Control Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 21, 2015; 21(27): 8358-8365
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8358
Table 1 Characteristics of the early gastric cancer and advanced gastric cancer groups n (%)
OverallEGC groupAGC groupP value
(n = 413)(n = 184)(n = 229)
Mean age (mean ± SD, yr)61.3 ± 11.662.1 ± 10.260.8 ± 12.60.263
Gender
Male293 (70.9)137 (74.5)156 (68.1)0.159
Female120 (29.1)47 (25.5)73 (31.9)
Smoking229 (55.4)110 (59.8)109 (47.6)0.014
Alcohol190 (46.0)97 (52.7)93 (40.6)0.014
H. pylori infection258 (62.5)105 (57.1)153 (66.8)0.042
Histology
Differentiated262 (63.4)184 (100)78 (34.1)< 0.001
Undifferentiated151 (36.6)0151 (65.9)
Follow-up duration (mean ± SD, months)37.2 ± 15.936.9 ± 14.937.4 ± 16.70.697
Table 2 Incidence of second primary cancers in gastric cancer patients n (%)
OverallEGC groupAGC groupP value
(n = 413)(n = 184)(n = 229)
Second primary cancer38 (9.2)17 (9.2)21 (9.2)0.981
Synchronous cancer18 (4.4)8 (4.3)10 (4.4)0.993
Metachronous cancer20 (4.8)9 (4.9)11 (4.8)0.967
Table 3 Distribution of second primary cancers according to gastric cancer group n (%)
LocationOverallEGC groupAGC group
(n = 38)(n = 17)(n = 21)
Lung7 (18.4)3 (17.6)4 (19.0)
Colorectal5 (13.2)2 (11.8)3 (14.3)
Esophagus5 (13.2)2 (11.8)3 (14.3)
Urogenital4 (10.5)2 (11.8)2 (9.5)
Gynecologic3 (7.9)1 (5.9)2 (9.5)
Pancreas3 (7.9)1 (5.9)2 (9.5)
Skin2 (5.3)1 (5.9)1 (4.8)
Hematology2 (5.3)1 (5.9)1 (4.8)
Others7 (18.3)4 (23.4)3 (14.3)
Table 4 Logistic regression analysis of risk factors in the early gastric cancer group
Synchronous cancer
Metachronous cancer
OR (95%CI)P valueOR (95%CI)P value
Age (> 60 yr)0.676 (0.082-5.580)0.5891.151 (0.278-4.768)0.846
Sex (male)0.992 (0.193-5.104)0.9921.488 (0.356-6.214)0.586
Smoking0.392 (0.091-1.696)0.2101.307 (0.316-5.408)0.712
Alcohol0.501 (0.116-2.165)0.3550.418 (0.101-1.726)0.228
H. pylori infection1.294 (0.299-5.594)0.7301.553 (0.376-6.421)0.543